Nerviano Medical Sciences S.r.l.: Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Inhibitor Asset
Terrence West, MBA, joins as New Business, Virtual CEO Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and
United States San Francisco Kostenloser Wertpapierhandel Lisa Mahnke Head Of Program Management Program Management
Source: finanznachrichten.de